(Q46613450)

23 December 2017

title

Inhibitors of epidermoid growth factor receptor suppress cell growth and enhance chemosensitivity of nasopharyngeal cancer cells in vitro (English)

1 reference

23 December 2017

1 reference

5

1 reference

23 December 2017

Chih-Hung Hsu

object named as

Chih-Hung Hsu

1

0 references

author name string

Ming Gao

2

1 reference

23 December 2017

Chi-Long Chen

3

1 reference

23 December 2017

Pei-Yen Yeh

4

1 reference

23 December 2017

publication date

20 July 2005

1 reference

23 December 2017

published in

Oncology

1 reference

23 December 2017

volume

68

1 reference

23 December 2017

issue

4-6

1 reference

23 December 2017

page(s)

538-547

1 reference

23 December 2017

Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells

cites work

1 reference

Epidermal growth factor receptor: mechanisms of activation and signalling.

21 January 2018

1 reference

Epidermal growth factor receptor inhibition in cancer therapy: biology, rationale and preliminary clinical results

21 January 2018

1 reference

The epidermal growth factor receptor family as a central element for cellular signal transduction and diversification

21 January 2018

1 reference

The epidermal growth factor receptor as a target for cancer therapy

21 January 2018

1 reference

Status of epidermal growth factor receptor antagonists in the biology and treatment of cancer

21 January 2018

1 reference

Phase I safety, pharmacokinetic, and pharmacodynamic trial of ZD1839, a selective oral epidermal growth factor receptor tyrosine kinase inhibitor, in patients with five selected solid tumor types.

21 January 2018

1 reference

Phase II trial of cetuximab in patients with refractory colorectal cancer that expresses the epidermal growth factor receptor.

21 January 2018

1 reference

IMC-C225, an anti-epidermal growth factor receptor monoclonal antibody for treatment of head and neck cancer

21 January 2018

1 reference

Inhibitors of epidermal-growth-factor receptors: a review of clinical research with a focus on non-small-cell lung cancer

21 January 2018

1 reference

Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer: a randomized trial

21 January 2018

1 reference

Multi-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non-small-cell lung cancer (The IDEAL 1 Trial) [corrected].

21 January 2018

1 reference

Undifferentiated nasopharyngeal cancer (UCNT): current diagnostic and therapeutic aspects

21 January 2018

1 reference

Epstein-Barr virus infection in the pathogenesis of nasopharyngeal carcinoma

21 January 2018

1 reference

The role of chemotherapy in the management of nasopharyngeal carcinoma

21 January 2018

1 reference

Prognostic value of multidrug resistance 1, glutathione-S-transferase-pi and p53 in advanced nasopharyngeal carcinoma treated with systemic chemotherapy

21 January 2018

1 reference

New prognostic factors in nasopharyngeal carcinoma. Tumor angiogenesis and C-erbB2 expression

21 January 2018

1 reference

Epstein-Barr virus-encoded latent membrane protein 1 co-expresses with epidermal growth factor receptor in nasopharyngeal carcinoma

21 January 2018

1 reference

Prognostic significance of tumor angiogenesis, Ki 67, p53 oncoprotein, epidermal growth factor receptor and HER2 receptor protein expression in undifferentiated nasopharyngeal carcinoma--a prospective study.

21 January 2018

1 reference

Prognostic value of epidermal growth factor receptor expression in patients with advanced stage nasopharyngeal carcinoma treated with induction chemotherapy and radiotherapy

21 January 2018

1 reference

Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs): simple drugs with a complex mechanism of action?

21 January 2018

1 reference

The phosphoinositide 3-kinase pathway

21 January 2018

1 reference

The phosphatidylinositol 3-Kinase AKT pathway in human cancer

21 January 2018

1 reference

Involvement of PI3K/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: a target for cancer chemotherapy.

21 January 2018

1 reference

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

21 January 2018

1 reference

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000086998

1 reference

23 December 2017

1 reference

23 December 2017